iRhythm targets $675M-$685M revenue for 2025 driven by Zio adoption and international expansion (NASDAQ:IRTC) | Seeking Alpha
Discover key insights from iRhythm Technologies' Q4 2024 earnings call. Learn about 24% revenue growth, Zio adoption, FDA progress, and 2025 guidance.